Papers
10
Total Citations
129
H-Index
6
About
Muhieddine Labban is a urologic surgeon and researcher whose work centers on improving surgical outcomes and access to care for prostate cancer patients. His primary research areas include the cost-effectiveness and safety of robotic-assisted radical prostatectomy (RARP), patient-reported functional outcomes, and the integration of novel technologies like aquablation and telementoring. Labban’s major contributions include a landmark cost-effectiveness analysis of robotic prostatectomy in the UK (46 citations), which informs ongoing debates about surgical resource allocation. He has also led studies identifying preoperative predictors of prolonged hospital stay and characterizing urinary and sexual recovery in the first year after surgery, using large national databases like NSQIP. His work on same-day discharge trends before and during the COVID-19 pandemic (6 and 4 citations) demonstrates a commitment to optimizing perioperative care and healthcare system resilience. Notably, Labban has pioneered the use of telemetry for aquablation adoption and developed a nomogram incorporating the platelet-to-lymphocyte ratio to predict lymph node involvement in prostate cancer. His research bridges clinical outcomes, health economics, and technological innovation, making him a key voice in modern urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9Impact of COVID-19 pandemic on ambulatory urologic oncology surgeries.2 citations · 2023
- 10